Page last updated: 2024-08-16

salmeterol xinafoate and Edema, Pulmonary

salmeterol xinafoate has been researched along with Edema, Pulmonary in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (91.67)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chandramoorthi, GD; Marimuthu, P; Piramanayagam, S1
Boyle, S; Dunin-Bell, O1
Auerbach, PS; Grissom, CK; Hackett, PH; Luks, AM; McIntosh, SE; Rodway, GW; Schoene, RB; Zafren, K1
Cruden, NL; Newby, DE; Webb, DJ1
Bärtsch, P; Mairbäurl, H1
Fang, X; Frank, JA; Matthay, MA; McAuley, DF1
Mutlu, GM; Sznajder, JI1
Pandit, A1
Fagenholz, PJ; Gutman, JA; Harris, NS; Murray, AF1
Frank, JA; Matthay, MA; Osorio, O; Wang, Y1
Voelkel, NF1
Allemann, Y; Cook, S; Duplain, H; Egli, M; Hugli, O; Hutter, D; Lepori, M; Lipp, E; Nicod, P; Sartori, C; Scherrer, U; Turini, P1

Trials

1 trial(s) available for salmeterol xinafoate and Edema, Pulmonary

ArticleYear
Salmeterol for the prevention of high-altitude pulmonary edema.
    The New England journal of medicine, 2002, May-23, Volume: 346, Issue:21

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Altitude Sickness; Biological Transport, Active; Double-Blind Method; Epithelium; Female; Humans; Hypertension, Pulmonary; Hypoxia; Male; Membrane Potentials; Middle Aged; Nasal Mucosa; Pulmonary Alveoli; Pulmonary Edema; Salmeterol Xinafoate; Sodium

2002

Other Studies

11 other study(ies) available for salmeterol xinafoate and Edema, Pulmonary

ArticleYear
An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine.
    Journal of molecular modeling, 2008, Volume: 14, Issue:9

    Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Altitude Sickness; Amino Acid Sequence; Binding Sites; Bronchodilator Agents; Computer Simulation; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Molecular Structure; Molecular Weight; Nifedipine; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Pulmonary Edema; Receptors, Adrenergic, beta-2; Reproducibility of Results; Salmeterol Xinafoate; Sequence Homology, Amino Acid; Spectrum Analysis, Raman; Vasodilator Agents

2008
Secondary prevention of HAPE in a Mount Everest summiteer.
    High altitude medicine & biology, 2009,Fall, Volume: 10, Issue:3

    Topics: Acetazolamide; Adult; Albuterol; Altitude; Bronchodilator Agents; Diuretics; Humans; Male; Mountaineering; Piperazines; Pulmonary Edema; Purines; Salmeterol Xinafoate; Secondary Prevention; Sildenafil Citrate; Sulfones; Vasodilator Agents

2009
Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness.
    Wilderness & environmental medicine, 2010, Volume: 21, Issue:2

    Topics: Acetazolamide; Acute Disease; Albuterol; Altitude Sickness; Brain Edema; Carbolines; Dexamethasone; Humans; Mountaineering; Nifedipine; Piperazines; Pulmonary Edema; Purines; Salmeterol Xinafoate; Sildenafil Citrate; Societies; Sulfones; Tadalafil; Wilderness Medicine

2010
Salmeterol for the prevention of high-altitude pulmonary edema.
    The New England journal of medicine, 2002, Oct-17, Volume: 347, Issue:16

    Topics: Albuterol; Altitude Sickness; Biological Transport, Active; Epithelium; Hemodynamics; Humans; Nitric Oxide; Pulmonary Alveoli; Pulmonary Edema; Salmeterol Xinafoate; Sodium

2002
Salmeterol for the prevention of high-altitude pulmonary edema.
    The New England journal of medicine, 2002, Oct-17, Volume: 347, Issue:16

    Topics: Adrenergic beta-Agonists; Albuterol; Altitude Sickness; Blood Pressure; Bronchodilator Agents; Echocardiography, Doppler; Humans; Pulmonary Alveoli; Pulmonary Artery; Pulmonary Edema; Salmeterol Xinafoate; Sodium

2002
Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury.
    Critical care medicine, 2004, Volume: 32, Issue:7

    Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Albuterol; Animals; Extravascular Lung Water; Pulmonary Alveoli; Pulmonary Edema; Pulmonary Gas Exchange; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Salmeterol Xinafoate; Stereoisomerism

2004
beta(2)-Agonists for treatment of pulmonary edema: ready for clinical studies?
    Critical care medicine, 2004, Volume: 32, Issue:7

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Humans; Pulmonary Alveoli; Pulmonary Edema; Rats; Respiratory Distress Syndrome; Salmeterol Xinafoate; Up-Regulation

2004
The physiologic basis of high-altitude diseases.
    Annals of internal medicine, 2005, Apr-05, Volume: 142, Issue:7

    Topics: Adrenergic beta-Agonists; Albuterol; Altitude Sickness; Animals; Extravascular Lung Water; Humans; Pulmonary Edema; Salmeterol Xinafoate

2005
Treatment of high altitude pulmonary edema at 4240 m in Nepal.
    High altitude medicine & biology, 2007,Summer, Volume: 8, Issue:2

    Topics: Acetazolamide; Adult; Albuterol; Altitude; Altitude Sickness; Bed Rest; Emergency Treatment; Female; Humans; Male; Middle Aged; Mountaineering; Nepal; Nifedipine; Oxygen Inhalation Therapy; Piperazines; Pulmonary Edema; Purines; Salmeterol Xinafoate; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents

2007
Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats.
    Journal of applied physiology (Bethesda, Md. : 1985), 2000, Volume: 89, Issue:4

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Atrial Function, Left; Bronchodilator Agents; Cattle; Hemodynamics; Humans; Lymph; Nebulizers and Vaporizers; Pulmonary Alveoli; Pulmonary Edema; Rats; Salmeterol Xinafoate; Serum Albumin, Bovine; Sheep

2000
High-altitude pulmonary edema.
    The New England journal of medicine, 2002, May-23, Volume: 346, Issue:21

    Topics: Adrenergic beta-Agonists; Albuterol; Altitude Sickness; Biological Transport, Active; Epithelium; Humans; Membrane Potentials; Pulmonary Alveoli; Pulmonary Edema; Salmeterol Xinafoate; Sodium

2002